MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Relationship between gait speed and functional measurements in Parkinson’s disease

    D. Iucksch, B. Yamaguchi, L. Araujo, V. Israel (CURITIBA, Brazil)

    Objective: The present study aims to relate gait speed in Parkinson's disease (PD) with functional measures of muscle strength, balance and physical capacity. Background: PD…
  • 2022 International Congress

    STN-DBS Targeting SNr Modulates Sleep in Parkinson’s Disease: A Proof-of-Concept Study

    HL. Yu, LX. Guan, YN. Sui, F. Ba, LM. Li (Beijing, China)

    Objective: To explore how subthalamic deep brain stimulation (STN-DBS) targeting substantia nigra pars reticulata (SNr) can modulate sleep in Parkinson’s disease (PD) patients with electrophysiologic…
  • 2022 International Congress

    Pseudodystonia due to Palmaris Brevis Syndrome: Case Report

    D-Y. Liou, A. Alamoudi, D. Preston, C. Kilbane (Cleveland, USA)

    Objective: We describe a case of pseudodystonia caused by palmaris brevis syndrome. Background: Palmaris brevis (PB) syndrome is a pseudodystonia characterized by spontaneous, involuntary, nonpainful…
  • 2022 International Congress

    Mosaicism for somatic SNCA copy number variants in multiple system atrophy is related to pathological subtype and presence of α-synuclein inclusions

    C. Proukakis, M. Garcia-Segura, D. Perez-Rodriguez, Z. Jaunmuktane (London, United Kingdom)

    Objective: To investigate the correlation of somatic copy number variants (CNVs) of the alpha-synuclein gene (SNCA) in multiple system atrophy (MSA) with disease subtype, and…
  • 2022 International Congress

    Assessment of non-motor symptoms of Parkinson’s disease in the long-term follow-up after the cell therapy

    V. Chyzhyk, A. Boika, V. Ponomarev (Minsk, Belarus)

    Objective: To evaluate the results of the introduction of MSCs on the non-motor symptoms in patients with PD within 12 months after the cell therapy.…
  • 2022 International Congress

    A qualitative study exploring the treatment burden and capacity of people with Parkinson’s and their caregivers

    QY. Tan, H. Roberts, S. Fraser, K. Ibrahim (Southampton, United Kingdom)

    Objective: To explore experiences of treatment burden and capacity in Parkinson’s and identify potentially modifiable factors that can improve this Background: Treatment burden, the workload…
  • 2022 International Congress

    Volumetric analysis of the Corpus Callosum in Hereditary Cerebellar Ataxia

    A. Adarmes Gomez, M. Reina, M. Grothe, M. Labrador-Espinosa, S. Jesus, D. Garcia, L. Muñoz-Delgado, F. Carrillo-Garcia, P. Mir (Sevilla, Spain)

    Objective: To analyze corpus callosum (CC) volumes on MRI in patients under follow-up for confirmed or suspected hereditary cerebellar ataxia Background: It is recognized that…
  • 2022 International Congress

    Subclinical cognitive patterns of caudate-anchored connectivity in early Parkinson’s disease

    S-W. Yoo, J-S. Kim, K-S. Lee (Seoul, Republic of Korea)

    Objective: This study is aimed at elucidating the changes of cognitive connectivity according to orthostatic stress in early Parkinson’s disease (PD). Background: 18F-Florbetaben tracer can…
  • 2022 International Congress

    Inflammatory biomarkers in newly diagnosed patients with Parkinson’s disease

    C. Pedersen, A. Ushakova, G. Alves, O-B. Tysnes, D. Aarsland, J. Lange, J. Maple-Grødem (Sandnes, Norway)

    Objective: To identify a panel of cerebrospinal fluid (CSF) inflammatory biomarkers for Parkinson’s disease (PD) and to compare levels of inflammatory proteins in control subjects…
  • 2022 International Congress

    Understanding patient perceptions of the key components of Medication Adherence in PD: a multicenter, international study

    M. Tosin, C. Goetz, D. Hall, G. Stebbins, B. Oliveira (Chicago, USA)

    Objective: To understand how patients with Parkinson's disease (PD) and their care partners describe medication adherence. Background: Medication adherence in is a complex construct, associated…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley